MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of 61.91 million. The enterprise value is 156.55 million.
Market Cap | 61.91M |
Enterprise Value | 156.55M |
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024.
Earnings Date | Nov 6, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MariMed has 381.00 million shares outstanding. The number of shares has increased by 2.54% in one year.
Shares Outstanding | 381.00M |
Shares Change (YoY) | +2.54% |
Shares Change (QoQ) | +1.15% |
Owned by Insiders (%) | 10.11% |
Owned by Institutions (%) | 0.30% |
Float | 342.49M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.39 |
PB Ratio | 0.88 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.32, with an EV/FCF ratio of -72.78.
EV / Earnings | -9.01 |
EV / Sales | 1.00 |
EV / EBITDA | 7.32 |
EV / EBIT | 17.03 |
EV / FCF | -72.78 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 1.00.
Current Ratio | 1.30 |
Quick Ratio | 0.46 |
Debt / Equity | 1.00 |
Debt / EBITDA | 4.10 |
Debt / FCF | -40.70 |
Interest Coverage | 1.24 |
Financial Efficiency
Return on equity (ROE) is -18.21% and return on invested capital (ROIC) is 3.35%.
Return on Equity (ROE) | -18.21% |
Return on Assets (ROA) | 2.89% |
Return on Capital (ROIC) | 3.35% |
Revenue Per Employee | 228,842 |
Profits Per Employee | -25,479 |
Employee Count | 721 |
Asset Turnover | 0.78 |
Inventory Turnover | 3.17 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.29% in the last 52 weeks. The beta is 2.80, so MariMed's price volatility has been higher than the market average.
Beta (5Y) | 2.80 |
52-Week Price Change | -54.29% |
50-Day Moving Average | 0.18 |
200-Day Moving Average | 0.23 |
Relative Strength Index (RSI) | 47.49 |
Average Volume (20 Days) | 409,061 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.27 |
Income Statement
In the last 12 months, MariMed had revenue of 156.07 million and -17.38 million in losses. Loss per share was -0.05.
Revenue | 156.07M |
Gross Profit | 67.54M |
Operating Income | 9.19M |
Pretax Income | -9.81M |
Net Income | -17.38M |
EBITDA | 19.31M |
EBIT | 9.19M |
Loss Per Share | -0.05 |
Balance Sheet
The company has 10.19 million in cash and 87.54 million in debt, giving a net cash position of -77.35 million or -0.20 per share.
Cash & Cash Equivalents | 10.19M |
Total Debt | 87.54M |
Net Cash | -77.35M |
Net Cash Per Share | -0.20 |
Equity (Book Value) | 87.60M |
Book Value Per Share | 0.18 |
Working Capital | 12.40M |
Cash Flow
In the last 12 months, operating cash flow was 17.53 million and capital expenditures -19.68 million, giving a free cash flow of -2.15 million.
Operating Cash Flow | 17.53M |
Capital Expenditures | -19.68M |
Free Cash Flow | -2.15M |
FCF Per Share | -0.01 |
Margins
Gross margin is 43.27%, with operating and profit margins of 5.89% and -11.13%.
Gross Margin | 43.27% |
Operating Margin | 5.89% |
Pretax Margin | -6.29% |
Profit Margin | -11.13% |
EBITDA Margin | 12.37% |
EBIT Margin | 5.89% |
FCF Margin | -1.38% |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.54% |
Shareholder Yield | -2.54% |
Earnings Yield | -28.44% |
FCF Yield | -3.47% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.86. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.86 |
Piotroski F-Score | n/a |